The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Vanck Zhu is an analyst at Guggenheim. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/09/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11/08/2023 | IDYA | Buy Now | IDEAYA Biosciences | $14.23 | 209.21% | Vanck Zhu75% | $48 → $44 | Maintains | Buy | Get Alert |
| 05/04/2023 | IONS | Buy Now | Ionis Pharmaceuticals | $25.20 | 249.21% | Vanck Zhu75% | $92 → $88 | Maintains | Overweight | Get Alert |
| 04/24/2023 | IDYA | Buy Now | IDEAYA Biosciences | $14.23 | 181.1% | Vanck Zhu75% | $32 → $40 | Maintains | Buy | Get Alert |
| 08/01/2017 | FWRD | Buy Now | Forward Air | $10.44 | — | Vanck Zhu75% | — | Downgrade | Outperform → Peer Perform | Get Alert |
